Skip to main content

Acetazolamide (International)

Note: In some countries, this medicine may only be approved for veterinary use.

In the US, Acetazolamide (acetazolamide systemic) is a member of the following drug classes: carbonic anhydrase inhibitor anticonvulsants, carbonic anhydrase inhibitors and is used to treat Edema, Epilepsy, Glaucoma, Hydrocephalus, Hypokalemic Periodic Paralysis, Mountain Sickness / Altitude Sickness, Pseudotumor Cerebri, Seizure Prevention and Seizures.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

S01EC01

CAS registry number (Chemical Abstracts Service)

0000059-66-5

Chemical Formula

C4-H6-N4-O3-S2

Molecular Weight

222

Therapeutic Categories

Glaucoma treatment

Carbonic anhydrase inhibitor

Diuretic agent

Chemical Names

N-(5-Sulfamoyl-1,3,4-tiadiazol-2-yl)acetamide (BAN, JAN)

2-Acetamido-1,3,4-tiadiazole-5-sulfonamide (WHO)

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs